BTQ Technologies Corp. Appoints Dr. Ro Cammarota to Accelerate QCIM Product Development

BTQ Technologies Corp. announced the appointment of Dr. Ro Cammarota to its U.S. team. Dr. Cammarota will focus on accelerating the development, commercialization, and strategic partnerships for QCIM, the company's post-quantum semiconductor platform. With over 20 years of experience in cryptography, privacy, and advanced chip design, including roles at Intel Labs, Qualcomm, and the U.S. Department of Defense, Dr. Cammarota is expected to strengthen BTQ's QCIM roadmap. His expertise will be crucial in advancing core IP, certification, industry partnerships, and go-to-market execution as BTQ moves towards broader commercial deployment of its post-quantum hardware platform. Dr. Cammarota's background includes significant contributions to cryptographic hardware innovation and public-private collaborations. He holds M.S. and Ph.D. degrees in Computer Science from UC Irvine.